Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
A new analysis of the first two patients treated in a clinical trial with CAR T cell therapy explains the longest persistence of CAR T cells recorded to date against chronic lymphocytic leukemia an
Read moreTwo Patients Declared 'Cured' of Leukemia a Decade After CAR T Cell Immunotherapy Infusion
Report in Nature analyzes CAR T cell therapy against chronic lymphocytic leukemia in first two patients with sustained remission a decade after infusion.
Read morePenn Spinout Verismo Therapeutics Raises $16M to Advance Cell Therapies
Cellular therapy in preclinical development to target pancreatic cancer, mesothelioma and ovarian cancer.
Read moreDr. Carl June Receives Leadership in Personalized Medicine Award
Personalized Medicine Coalition award recognizes new era in precision medicine with treatments characterized by ability to alter molecular characteristics of patients’ own cells.
Read moreResearch Lab Update
Update March 18: Message to PLM Research Faculty: NIH COVID-19 announcements and PSOM-mandated lab ramp-down.
Read moreResearch Lab Update
Update March 16: Message to PLM Research Faculty regarding lab ramp-down as mandated by PSOM leadership.
Read more
